ARTV vs IT · rev $251.0K vs P/E 16, rev $6.27B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ARTV currently screens at market cap $37.3M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ARTV and IT stock pages for the full models.
Not investment advice.